Serum Soluble CD25 in Hepatocellular Carcinoma, Shall We Able to Change the Natural History?

Journal Title: Journal of Cancer and Tumor International - Year 2017, Vol 5, Issue 4

Abstract

Background: Although hepatocellular carcinoma (HCC) is one of the most common malignancy related mortality worldwide, it can be curable if detected in early stages. Axiomatically, emergence of a new marker for early prediction of HCC could enable to apply the proper treatment strategy early in the course of the disease and therefore ameliorates the outcome. Aim: To evaluate the performance of serum soluble CD25 (sCD25) in the prediction of early HCC and compare it to α-fetoprotein (AFP); the classical biomarker of HCC. Methods: Serum levels of sCD25 and AFP were measured in three groups of population; HCC group (40 patients), cirrhosis without HCC control group (20 patients) and healthy control group (20 patients). HCC group contained 20 early and 20 late stage patients according to Tumor Lymph Node Metastasis (TNM) staging system (stage I/II and III/IV respectively). Levels of both biomarkers were compared in all groups. Predictive yield of both biomarkers for early HCC was evaluated using ROC curve analysis. Results: Level of sCD25 was significantly higher in patients with HCC than in both cirrhotic controls and healthy controls (P<0.0001and 0.013 respectively). For the presence of HCC, sensitivity and specificity of sCD25 were 90% and 84.2% respectively at a cut-off value of 7 ng/ml (AUC=0.969; P<0.0001). For prediction of early HCC in patients with cirrhosis, the optimal sCD25 cutoff level was 7.15 ng/ml with sensitivity and specificity of 90% and 60% respectively (AUC=0.717; P=0.019) while sensitivity and specificity of AFP were 70% and 85% respectively at a cut-off value of 9.85 ng/ml (AUC=0.781; P=0.002) in the same settings. Conclusion: sCD25 seems to be a reliable biomarker for early detection of HCC and therefore could enhance the outcome.

Authors and Affiliations

Eman Abdel Sameea, Talaat Zakareya, Khaled Metwaly, Anas Abdel Rahman, Howyda Mohammed Kamal, Wafaa Mohammed Abdalla

Keywords

Related Articles

Outcome and Predictive Factors of Radiation Therapy for Medulloblastoma: Mansoura Experience

Background: Medulloblastomas are the most common infratentorial malignant brain tumors with an incidence rate of 0.5 in 100.000 typically arising in childhood at age 5-9 years. Aim of Work: Exploring the epidemiological...

Kolaviron an Active Biflavonoid of Garcinia kola Extract Prevent 1,2-dimethylhydrazine Induced Oxidative Stress and Lipid Peroxidation in the Initiation Phase of Colon Carcinogenesis in Wistar Rats

Colon cancer is steadily increasing in Africa with high mortality and it is a pathological consequence of persistent oxidative stress. Kolaviron an active biflavonoid, has been shown to possess antioxidant, anti-lipid pe...

Photodynamic Therapy for Vulvar Carcinoma in situ (Case Report)

The article presents a clinical case of the successful application of photodynamic therapy with chlorine e6-based photosensitizer photolon in a patient with vulvar cancer in situ. The use of an exposure dose of light of...

MiRNA and Target Oncogene Regulation in Triple Negative Breast Cancer: An Age, Ethnic and Environmental Related Neoplastic Event

Triple-negative breast cancer is a type of aggressive breast cancer without the immunohistochemical expression of estrogen receptors, progesterone receptors and human epidermal growth factor receptor-2; with poor prognos...

The Relationship between Single Nucleotide Polymorphisms of Gene XRCC1 and Toxicity Induced Radiation in Patients with Head and Neck Cancer

Aims: The head and neck cancer is one of the most common types and their treatment brings complications such as dermatitis, mucositis and dysphagia. Studies of genetic variations of patients are those that enable the ide...

Download PDF file
  • EP ID EP309100
  • DOI 10.9734/JCTI/2017/35735
  • Views 109
  • Downloads 0

How To Cite

Eman Abdel Sameea, Talaat Zakareya, Khaled Metwaly, Anas Abdel Rahman, Howyda Mohammed Kamal, Wafaa Mohammed Abdalla (2017). Serum Soluble CD25 in Hepatocellular Carcinoma, Shall We Able to Change the Natural History?. Journal of Cancer and Tumor International, 5(4), 1-7. https://europub.co.uk./articles/-A-309100